However, compounding pharmacies must still follow strict guidelines set by state boards of pharmacy and adhere to USP (United States Pharmacopeia) standards for quality and safety
[30] Regular monitoring as recommended by your healthcare team should include assessment of treatment response, adverse effects, and overall health status
Clinical trials such as REWIND have demonstrated that GLP-1 receptor agonists provide cardiovascular benefits while on treatment, and these advantages are not expected to persist when treatment is discontinued unless replaced with alternative therapy
Collaboration among the care team members is essential
Chronic low-grade inflammation contributes to obesity-related comorbidities [123, 124], and the MD has consistently demonstrated immunomodulatory effects, even in the absence of weight loss [123, 124]